Ufp Technologies (UFPT) EPS (Basic) Growth (3y) (2013 - 2026)
Ufp Technologies (UFPT) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | -6.52% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 7.60% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 62.89% |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 60.34% |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 29.37% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 30.65% |
| 10 | Ufp Technologies | 1.91 Bn | 1.89 Bn | 44.36 Mn | 20.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.88% |
| Dec 31, 2025 | 26.78% |
| Sep 30, 2025 | -6.29% |
| Jun 30, 2025 | 23.59% |
| Mar 31, 2025 | 51.41% |
| Dec 31, 2024 | 70.90% |
| Sep 30, 2024 | 61.82% |
| Jun 30, 2024 | 41.28% |
| Mar 31, 2024 | 44.09% |
| Dec 31, 2023 | 39.78% |
| Sep 30, 2023 | 56.59% |
| Jun 30, 2023 | 71.38% |
| Mar 31, 2023 | 34.96% |
| Dec 31, 2022 | 12.86% |
| Sep 30, 2022 | 50.38% |
| Jun 30, 2022 | 23.99% |
| Mar 31, 2022 | 8.48% |
| Dec 31, 2021 | -10.67% |
| Sep 30, 2021 | -3.58% |
| Jun 30, 2021 | 4.87% |